CLINICAL_TRIALS
trial_result
· 2018-12-07
Clinical Trial Update: Dose-Response Profile of A-101 in Subjects With Seborrheic Keratosis [Phase 2]
Summary
Phase 2 trial update on dose-response profile of A-101 in seborrheic keratosis with completed status and results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Aclaris Therapeutics, Inc. | Conditions: Seborrheic Keratosis | Phase 2 | Status: COMPLETED | Results posted: 2018-12-07